JP2011521975A5 - - Google Patents

Download PDF

Info

Publication number
JP2011521975A5
JP2011521975A5 JP2011511889A JP2011511889A JP2011521975A5 JP 2011521975 A5 JP2011521975 A5 JP 2011521975A5 JP 2011511889 A JP2011511889 A JP 2011511889A JP 2011511889 A JP2011511889 A JP 2011511889A JP 2011521975 A5 JP2011521975 A5 JP 2011521975A5
Authority
JP
Japan
Prior art keywords
transdermal patch
adhesive
drug matrix
pharmaceutically active
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011511889A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011521975A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/045762 external-priority patent/WO2009146443A1/en
Publication of JP2011521975A publication Critical patent/JP2011521975A/ja
Publication of JP2011521975A5 publication Critical patent/JP2011521975A5/ja
Pending legal-status Critical Current

Links

JP2011511889A 2008-05-30 2009-05-30 医薬化合物の経皮送達のための組成物と方法 Pending JP2011521975A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12901508P 2008-05-30 2008-05-30
US61/129,015 2008-05-30
PCT/US2009/045762 WO2009146443A1 (en) 2008-05-30 2009-05-30 Compositions and methods for the transdermal delivery of pharmaceutical compounds

Publications (2)

Publication Number Publication Date
JP2011521975A JP2011521975A (ja) 2011-07-28
JP2011521975A5 true JP2011521975A5 (enExample) 2012-07-12

Family

ID=41377621

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011511889A Pending JP2011521975A (ja) 2008-05-30 2009-05-30 医薬化合物の経皮送達のための組成物と方法

Country Status (5)

Country Link
US (1) US20090297591A1 (enExample)
EP (1) EP2291157A4 (enExample)
JP (1) JP2011521975A (enExample)
TW (1) TWI435737B (enExample)
WO (1) WO2009146443A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
RU2477136C2 (ru) 2004-03-03 2013-03-10 Вайтал Хэлф Сайнсис Пти Лтд Алкалоидные составы
US9168216B2 (en) 2005-06-17 2015-10-27 Vital Health Sciences Pty. Ltd. Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
CN102164601A (zh) * 2008-09-30 2011-08-24 帝国制药美国公司 经皮延长给药多奈哌齐组合物及其使用方法
EP2298277A1 (en) * 2009-09-09 2011-03-23 Labtec GmbH Transdermal patch formulation
WO2011094814A1 (en) 2010-02-05 2011-08-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
KR101746204B1 (ko) * 2010-02-18 2017-06-13 에스케이케미칼주식회사 피부 투과가 개선된 톨테로딘의 경피 투여용 조성물
CA2794734C (en) 2010-03-30 2017-12-12 Phosphagenics Limited Transdermal delivery patch
EP2596071B1 (en) * 2010-07-21 2019-02-13 3M Innovative Properties Company Transdermal adhesive compositions, devices, and methods
WO2012017892A1 (ja) * 2010-08-03 2012-02-09 久光製薬株式会社 貼付剤及びその粘着力増強方法
TWI433904B (zh) 2011-01-12 2014-04-11 Taiwan Biotech Co Ltd 多奈哌齊經皮貼片
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
ES3034911T3 (en) 2011-05-10 2025-08-26 Itochu Chemical Frontier Corp Non-aqueous patch
MX349572B (es) 2011-05-10 2017-08-03 Itochu Chemical Frontier Corp Parche no acuoso.
US11786455B2 (en) 2011-05-10 2023-10-17 Itochu Chemical Frontier Corporation Non-aqueous patch
US10765640B2 (en) 2011-09-27 2020-09-08 Itochu Chemical Frontier Corporation Non-aqueous patch
US20130184351A1 (en) * 2011-12-21 2013-07-18 Jar Laboratories Lidocaine patch and methods of use thereof
WO2013099835A1 (ja) 2011-12-27 2013-07-04 帝國製薬株式会社 トルテロジン含有貼付剤
JP6269488B2 (ja) * 2012-09-03 2018-01-31 ニプロ株式会社 貼付剤
BR112018003617A2 (pt) * 2015-08-24 2018-12-11 Itochu Chemical Frontier Corp adesivo não aquoso compreendendo lidocaína e método para administrar referido adesivo
US10973761B2 (en) 2015-12-09 2021-04-13 Phosphagenics Limited Pharmaceutical formulation
JP7198754B2 (ja) 2016-12-21 2023-01-04 アベーチョ バイオテクノロジー リミテッド 方法
DE102017127433A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices
CN110638832A (zh) * 2019-11-07 2020-01-03 蚌埠丰原医药科技发展有限公司 一种纳米银利多卡因抗菌止痛贴及其制备方法
WO2022125624A1 (en) * 2020-12-09 2022-06-16 Vizuri Health Sciences Consumer Healthcare, Inc. Highly elastic patches and masks for delivery of therapeutic agents
JP2024530821A (ja) * 2021-09-09 2024-08-23 アンドロス ファーマシューティカルズ シーオー．，エルティディー． 局所麻酔剤－粘土複合組成物
JP7179212B1 (ja) 2022-05-02 2022-11-28 久光製薬株式会社 リドカイン含有貼付剤

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2694964B2 (ja) * 1988-04-25 1997-12-24 帝國製薬株式会社 歯肉適用型局所麻酔貼付剤
US5411738A (en) * 1989-03-17 1995-05-02 Hind Health Care, Inc. Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine
JP3193161B2 (ja) * 1992-10-23 2001-07-30 久光製薬株式会社 経皮吸収性製剤
JP3066515B2 (ja) * 1992-11-11 2000-07-17 久光製薬株式会社 尿失禁治療用経皮投与製剤
US5601839A (en) * 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
US5693335A (en) * 1995-06-07 1997-12-02 Cygnus, Inc. Skin permeation enhancer composition for use with sex steroids
SE9802864D0 (sv) * 1998-08-27 1998-08-27 Pharmacia & Upjohn Ab Transdermally administered tolterodine as antimuscarinic agent for the treatment of overactive bladder
DE19922662C1 (de) * 1999-05-18 2000-12-28 Sanol Arznei Schwarz Gmbh Transdermales therapeutisches System (TTS) Tolterodin enthaltend
US7537785B2 (en) * 1999-10-29 2009-05-26 Nitromed, Inc. Composition for treating vascular diseases characterized by nitric oxide insufficiency
WO2001032115A1 (en) * 1999-11-04 2001-05-10 Xel Herbaceuticals Transdermal administration of huperzine
US6562368B2 (en) * 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers
JP2001302501A (ja) * 2000-04-17 2001-10-31 Oishi Koseido:Kk 肩こり・膝関節痛・五十肩等の治療用貼付剤
US20020019421A1 (en) * 2000-07-05 2002-02-14 Roni Biberman Compositions and therapy for substance addiction
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
WO2002045701A2 (en) * 2000-12-05 2002-06-13 Noven Pharmaceuticals, Inc. Crystallization inhibition of drugs in transdermal drug delivery systems
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
CN1893931B (zh) * 2003-10-27 2011-07-20 陶氏康宁公司 局部用制剂及将活性剂传递给基底的方法
US20050266085A1 (en) * 2004-05-28 2005-12-01 Warner Kevin S Gelled emulsion and microemulsion formulations for dermal drug delivery
ITMI20041492A1 (it) * 2004-07-23 2004-10-23 Italiano Biochimico Far Maceut Nuovo dispositivo per il rilascio di principi attivi
AU2006322050A1 (en) * 2005-12-06 2007-06-14 Monosol Rx, Llc Topical film compositions for delivery of actives
US20070202155A1 (en) * 2006-02-03 2007-08-30 Cure Therapeutics, Inc. Low dose no donor-containing transdermal patch
US7879344B2 (en) * 2006-06-29 2011-02-01 Kimberly-Clark Worldwide, Inc. Transdermal delivery of oleocanthal for relief of inflammation
US20080008747A1 (en) * 2006-07-07 2008-01-10 Royds Robert B Transdermal patch
US9248104B2 (en) * 2006-08-17 2016-02-02 Core Tech Solutions, Inc. Transdermal methods and systems for treating Alzheimer's disease

Similar Documents

Publication Publication Date Title
FI3257504T3 (fi) Polyvinyylipyrrolidoni ei-kidemäisessä muodossa olevan rotigotiinin kiinteän dispersion stabiloimiseksi
TWI630110B (zh) 積層型貼附劑
WO2011060256A3 (en) Bilayer tablet formulations
CN107532050B (zh) 用于透皮给药的压敏粘合剂
WO2011011318A8 (en) Process for the continuous manufacture of a polyisobutylene based transdermal patch
WO2009059701A3 (de) Retardtabletten mit hydromorphon
JP2014503523A5 (enExample)
NZ589437A (en) Immediate release tablet comprising 5-azacytidine and a non-enteric coating applied with an ethanol solvent
JP2010510260A5 (enExample)
NZ600123A (en) Compressible-coated pharmaceutical compositions and tablets and methods of manufacture
WO2009113703A3 (en) Orally-disintegrating solid preparation
NZ611920A (en) Percutaneous absorption preparation containing rivastigmine
JP2013537526A5 (enExample)
JP2016504368A5 (enExample)
WO2009008006A3 (en) Pharmaceutical compositions for gastrointestinal drug delivery
WO2013148834A3 (en) Tissue thickness compensator comprising tissue ingrowth features
JP2011521975A (ja) 医薬化合物の経皮送達のための組成物と方法
JP2017515869A5 (enExample)
JP7072520B2 (ja) 二重ディスク経皮システム
WO2013009142A3 (en) Sustained/release pharmaceutical composition comripising choline alfoscerate or pharmaceutically acceptable salt thereof and method for manufacturing the same
WO2008151040A3 (en) Analgesic coated medical product
MX349917B (es) Composiciones farmaceuticas que comprneden pilocarpina.
JP2016505006A5 (enExample)
WO2011141791A3 (en) Extended release formulations of desvenlafaxine base
JP2011140504A5 (enExample)